Tsukuba, Japan

Hitomi Kondo

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Tsukuba, JP (2018 - 2019)
  • Ibaraki, JP (2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Hitomi Kondo

Introduction

Hitomi Kondo is a notable inventor based in Tsukuba, Japan, recognized for his significant contributions to the field of medicinal chemistry. With a total of two patents to his name, Kondo's work primarily revolves around innovative compounds that have promising applications in the treatment of various medical conditions.

Latest Patents

Kondo's latest patents focus on pyrrolopyrimidine compounds or their salts, along with compositions that incorporate these compounds. Notably, these patents detail the compounds' NAE inhibitory action and their ability to inhibit cell growth, making them potential candidates for anti-tumor agents. The detailed formulations, represented by Formula (A), illustrate Kondo's dedication to developing effective therapeutic solutions.

Career Highlights

Throughout his career at Taiho Pharmaceutical Company Limited, Hitomi Kondo has demonstrated an exceptional commitment to research and development in pharmaceutical innovations. His endeavors have contributed to advancing the understanding and treatment of complex diseases, particularly through the application of unique chemical compounds.

Collaborations

Kondo has collaborated with talented colleagues, including Takashi Mizutani and Chihoko Yoshimura. These partnerships have fostered an environment of innovation and teamwork, allowing for the successful execution of complex research projects and the development of groundbreaking medicinal products.

Conclusion

Hitomi Kondo's work exemplifies the impact that dedicated inventors can have in the pharmaceutical industry. Through his patents and collaborative efforts, he continues to push the boundaries of medicinal chemistry, offering hope for the development of new therapies to combat tumors and enhance patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…